VMD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Viemed Healthcare, Inc. (VMD).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
10.9%
ROIC, 4.4% FCF margin
Growth
15.5%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 1.2x current ratio
Superinvestors
1
Top: First Eagle Investment Management (0.0%)
Strengths to research
- Revenue compounded at 15.5% over five years.
- Debt/equity looks manageable at 0.0x.
- 8 annual periods are available for trend analysis.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 8 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for VMD.
Grade D
40
/ 100
Financial Charts
No financial data available for VMD (annual).
1 superinvestors own VMD
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 529,657 | $5M | 0.01% | 0.0% |